As is the case with leukemia cells, GBM cells may be able to modify actin cytoskeleton dynamics by increasing Cdc42 in pericyte cytoplasm, thus introducing adhesion and motility defects [79]. The gene discussed is CDC42; the disease is glioblastoma.